Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 14 38 39 706
2007 07 17 14 38 39 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

close

Latest in Molecular Imaging
A Rk Nx1 Fop15 Je H Jffj8rq D13
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
April 22, 2026
Isotopes1
Ionetix raises $30M to scale radioisotope production
April 21, 2026
Molecular Imaging News Platform: trends, insights, professional views.
Sponsored
Molecular Imaging News Platform: trends, insights, professional views.
April 14, 2026
Atom Molecule
MITA PET Group rebrands, expands scope to theranostics
April 20, 2026
Related Stories
2007 07 17 15 08 50 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Molecular Imaging News Platform: trends, insights, professional views.
Sponsor Content
Molecular Imaging News Platform: trends, insights, professional views.
More in Molecular Imaging
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
A Rk Nx1 Fop15 Je H Jffj8rq D13
Ionetix raises $30M to scale radioisotope production
By AuntMinnie.com staff writers
The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.
April 21, 2026
Isotopes1
FAPI-PET superior to FDG-PET in liver cancer
By Will Morton
The finding is from a prospective head-to-head comparison among 59 patients with suspicious lesions.
April 20, 2026
A 65-y-old man with HCC and liver cirrhosis confirmed by MRI. Ga-68 FAPI-46 PET/CT demonstrates increased focal uptake (SUVmax, 13.26, and TBRmax, 2.89) in liver, whereas F-18 FDG-PET/CT scans showed non–F-18 FDG-avid lesion (SUVmax, 3.24, and TBRmax, 1.43), indicated by solid arrows. Additionally, histologically proven adenocarcinoma in colon transversum was identified as pathologic with Ga-68 FAPI-46 alone (dashed arrows).
MITA PET Group rebrands, expands scope to theranostics
By AuntMinnie.com staff writers
The new name reflects an expanded focus beyond diagnostic radiopharmaceuticals to include theranostics.
April 20, 2026
Atom Molecule
Brain MRI, PET may predict who gains most from lifestyle interventions
By Kate Madden Yee
Brain MRI, PET could help identify which older adults are most likely to benefit from a structured lifestyle program.
April 20, 2026
Mri Brain Head
FDG-PET predicts outcomes in metastatic breast cancer
By Will Morton
Patients without disease progression on FDG-PET scans 14 days after treatment had better progression-free and overall survival.
April 16, 2026
Breast Cancer Social
Type of cardiac imaging before revascularization has shifted sharply
By Kate Madden Yee
Demographic disparities reveal modality-specific patterns, "underscoring the need for targeted interventions," researchers wrote.
April 16, 2026
Artery Heart 3 D Base Thumbnail
Telix doses first patient in glioblastoma trial
By AuntMinnie.com staff writers
The patient was dosed at Austin Health in Melbourne, Australia.
April 15, 2026
A Ibrain
Telix and Regeneron enter $2.1B partnership
By AuntMinnie.com staff writers
Regeneron to enter targeted radiopharmaceuticals sphere.
April 14, 2026
Business Deal Handshake
ARRS: Do GLP-1 drugs confound FDG-PET imaging scans?
By Will Morton
No significant differences in FDG uptake were observed in the skeletal muscle, liver, blood pool, or abdominal fat following GLP-1 agonist therapy.
April 13, 2026
Patient Pet
ARRS: MBI has considerations for streamlining breast imaging workflows
By Amerigo Allegretto
An ARRS presentation addressed how MBI workflows can be streamlined.
April 13, 2026
Screenshot (127)
New PET tracer shows promise in dementia
By Will Morton
SV2A PET may offer a robust, sensitive biomarker for disease staging, treatment monitoring.
April 10, 2026
(A) Averaged parametric images of F-18 SynVesT-1 BPND values and (B) F-18 FDG SUVR (60–90 minutes) values overlaid on anatomical (T1) images in MNI space show group differences between behavioral variant frontotemporal dementia (top) and healthy controls (middle). The color scale represents (A) BPND and (B) SUVR values. On the bottom, average z-score maps were generated to visualize regional reductions in F-18 SynVesT-1 BPND and F-18 FDG SUVR in bvFTD relative to healthy controls. For each voxel, z-scores were calculated as z = (bvFTD−meanHC )/SDHC. Negative z-scores indicate lower synaptic density or glucose metabolism in the bvFTD compared with controls in the regions. BPND, non-displaceable binding potential; bvFTD, behavioral variant frontotemporal dementia; F-18 FDG, F-18 fluorodeoxyglucose; MNI, Montreal Neurological Institute; SUVR, standardized uptake value ratio.
Page 1 of 624
Next Page